![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 19, 2018 8:53:22 PM
Seems strange at first thought with no ads or announcements, but there’s a method to the madness with a soft rollout. KN is absolutely brilliant and just drastically upped the leverage BIEL has in any negotiations with anyone IMO with this CVS intro. It is an incredible chess move! What’s not to like?
Maybe, I’m wrong, but if I were Bayer or another Big Phar., I’d be a bit nervous about Actipatch being on the CVS shelves with no agreement in hand. Did Bayer know before this board? Likely. But now it’s leaking out more and more. Not too much, but just enough, which is wise. Flying under the radar while the pressure builds. I like it. I like it a lot!
Seems like it’s sh@t or get off the pot time for all the big boys in a more urgent way. I think it will speed up negotiations considerably and seriously and clearly moves up BIEL’s worth. Someone better move on this soon or it will be...FDA full clearance, possibly FDA challenge...then...
CHECKMATE!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM